Showing results (41-50 of 75) with videos related to
Sort By:
Pageof 8
Current Medical Research and Opinion|April 12, 2021
Burden of allergic rhinitis and impact of MP-AzeFlu from the patient perspective: pan European patient surveyG Walter Canonica, Ludger Klimek, Sarah Acaster, et al.Current Allergy and Asthma Reports|December 5, 2024
Thymic Stromal Lymphopoietin (TSLP): Evidence in Respiratory Epithelial-driven Diseases Including Chronic Rhinosinusitis with Nasal PolypsEugenio De Corso, Peter W Hellings, Wytske J Fokkens, et al.Frontiers in Pharmacology|December 24, 2019
The Intriguing Role of Interleukin 13 in the Pathophysiology of AsthmaGiancarlo Marone, Francescopaolo Granata, Valentina Pucino, et al.The Journal of Allergy and Clinical Immunology|January 30, 2010
Long-term clinical efficacy in grass pollen-induced rhinoconjunctivitis after treatment with SQ-standardized grass allergy immunotherapy tabletStephen R Durham, Waltraud Emminger, Alexander Kapp, et al.Nature Reviews. Disease Primers|December 4, 2020
Allergic rhinitisJean Bousquet, Josep M Anto, Claus Bachert, et al.Journal of Asthma and Allergy|December 9, 2020
MP-AzeFlu Improves the Quality-of-Life of Patients with Allergic RhinitisRanny van Weissenbruch, Ludger Klimek, Gabriella Gálffy, et al.Current Medical Research and Opinion|July 19, 2024
Why fexofenadine is considered as a truly non-sedating antihistamine with no brain penetration: a systematic reviewIgnacio J Ansotegui, Jean Bousquet, Giorgio Walter Canonica, et al.International Forum of Allergy & Rhinology|July 14, 2021
A multicenter real-life study on the multiple reasons for uncontrolled allergic rhinitisPauline Van Bulck, Leen Cools, Mysore S Soumya, et al.The Journal of Allergy and Clinical Immunology|January 31, 2012
SQ-standardized sublingual grass immunotherapy: confirmation of disease modification 2 years after 3 years of treatment in a randomized trialStephen R Durham, Waltraud Emminger, Alexander Kapp, et al.The World Allergy Organization Journal|May 20, 2020
Allergic respiratory disease care in the COVID-19 era: A EUFOREA statementGlenis K Scadding, Peter W Hellings, Claus Bachert, et al.Pageof 8